Biotricity Inc. earnings releases BTCY

Biotricity Inc. last reported quarterly results on Feb 18, 2026, for Q3 FY2026 (the quarter ended Dec 31, 2025): revenue of $4.0 million (+10.2% year over year) and diluted EPS of -$0.04. It usually reports 49–55 days after a quarter ends.

Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 49–55 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.

Released Quarter Revenue Net income Diluted EPS
Feb 18, 2026
49 days after quarter end
Q3 FY2026
ended Dec 31, 2025
4
+10.2%
-1
+41.7%
-0.04
+22.2%
Nov 18, 2025
49 days after quarter end
Q2 FY2026
ended Sep 30, 2025
4
+18.9%
-1
+55.8%
-0.03
+60.3%
Feb 24, 2025
55 days after quarter end
Q3 FY2025
ended Dec 31, 2024
4
+21.7%
-1
+56.2%
-0.05
+84.1%
Nov 20, 2024
51 days after quarter end
Q2 FY2025
ended Sep 30, 2024
3
+13.0%
-2
+57.7%
-0.07
+83.4%
Jul 5, 2023
5 days after quarter end
—
ended Jun 30, 2023
—
—
—
Nov 18, 2022
49 days after quarter end
—
ended Sep 30, 2022
—
—
—
Jul 18, 2022
18 days after quarter end
—
ended Jun 30, 2022
—
—
—
Feb 16, 2022
47 days after quarter end
—
ended Dec 31, 2021
—
—
—

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
BTCY (OTC)
Fiscal year ends
March 31
Incorporated in
NV
Headquarters
Redwood City, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1630113
Former names
METASOLUTIONS, INC. (until Jan 5, 2016)

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.